僅用于工業(yè)應用或科學(xué)研究,不可用于人類(lèi)或動(dòng)物的臨床診斷或治療,非藥用. Onartuzumab (MetMAb) is a unique, humanized and affinity-matured monovalent (one-armed) monoclonal antibody against the MET receptor. Onartuzumab potently inhibits HGF binding and receptor phosphorylation and signaling. Onartuzumab has antibody-like pharmacokinetics and antitumor activity